Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » supg: FDA approval+bottom play

 - UBBFriend: Email this page to someone!    
Author Topic: supg: FDA approval+bottom play
ruskin_muskin
Member


Icon 1 posted      Profile for ruskin_muskin         Edit/Delete Post   Reply With Quote 
SuperGen Receives U.S. Patent For Nipent(R)(Pentostatin For Injection)
Friday June 2, 8:00 am ET
- Patent is First for SuperGen in Graft-versus-Host Disease -

DUBLIN, Calif., June 2 /PRNewswire-FirstCall/ -- SuperGen, Inc. (Nasdaq: SUPG - News) today announced the issuance of U.S. Patent No. 7,037,900 B2 entitled, "Composition and Method for Treating Graft-versus-Host Disease." The patent contains 39 claims relating to the composition and methods for treating graft-versus-host disease (GvHD) and, more specifically, to the administration of inhibitors of adenosine deaminase (ADA). In particular, novel formulations of ADA inhibitors such as pentostatin are utilized for suppressing T-lymphocyte mediated immune responses while minimizing systemic toxicity of the drug.

ADVERTISEMENT
"This is SuperGen's first patent relating to the use of Nipent® in graft-versus-host disease, and it enhances the potential value of our franchise beyond the current approved indication of Hairy Cell Leukemia," said Edward L. Jacobs, Chief Operating Officer. "Nipent® is being studied in a large number of trials in a variety of clinical settings. This patent supports the ongoing efforts of clinical investigators to explore further Nipent's utility in GvHD."

About Nipent

Nipent® (pentostatin for injection) is currently approved as a single-agent treatment for patients with Hairy Cell Leukemia, and is not approved as either a single agent or as part of a combination regimen for treatment for any other indication.

About Graft -versus -Host Disease (GvHD)

GvHD is a condition that results when the immune cells of a transplant (usually of bone marrow) from a donor attack the tissues of the person receiving the transplant.

shares shall soar on this news IMO!


http://stockcharts.com/h-sc/ui?s=SUPG&p=DAILY&b=5&g=0&id=p

--------------------
All my posts are based on my own opinions and not to be taken as buy/sell recommendations.

IP: Logged | Report this post to a Moderator
ruskin_muskin
Member


Icon 1 posted      Profile for ruskin_muskin         Edit/Delete Post   Reply With Quote 
called this * 4.25 in the morning. now its 4.34, up 3%, but thats only because markts are extremely slow. come monday this should fly...BOOM.. easy 10% to be made here without any loss at all! see charts... easy rebound play!

--------------------
All my posts are based on my own opinions and not to be taken as buy/sell recommendations.

IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share